Literature DB >> 12754577

A retrospective evaluation of a score system adopted by the Ministry of Health, Brazil in the diagnosis of pulmonary tuberculosis in childhood: a case control study.

Clemax Couto Sant'Anna1, Cláudia T S Orfaliais, Maria de Fátima B Pombo March.   

Abstract

Based on a retrospective case-control study we evaluated the score system adopted by the Ministry of Health of Brazil (Ministério da Saúde - MS), to diagnose pulmonary tuberculosis (PTB) in childhood. This system is independent of bacteriological or histopathological data to define a very likely (> or = 40 points), possible (30-35 points) or unlikely (< or = 25 points) diagnosis of tuberculosis. Records of hospitalized non-infected HIV children at the Instituto de Puericultura e Pediatria Martagão Gesteira of Federal University of Rio de Janeiro (IPPMG-UFRJ), were reviewed. Patients were adjusted for age and divided in two different groups: 45 subjects in the case group (culture-positive) [mean of age = 10.64 mo; SD 9.66]; and 96 in the control group (culture-negative and clinic criteria that dismissed the disease) [mean of age = 11.79 mo.; SD 11.31]. Among the variables analyzed, the radiological status had the greater impact into the diagnosis (OR = 25.39), followed by exposure to adult with tuberculosis (OR = 10.67), tuberculin skin test >10mm (OR = 8.23). The best cut-off point to the diagnosis of PTB was 30 points, where the score system was more accurate, with sensitivity of 88.9% and specificity of 86.5%.

Entities:  

Mesh:

Year:  2003        PMID: 12754577     DOI: 10.1590/s0036-46652003000200010

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  5 in total

Review 1.  Recent tuberculosis advances in Latin America.

Authors:  Tom Pelly; David A J Moore; Robert Gilman; Carlton Evans
Journal:  Curr Opin Infect Dis       Date:  2004-10       Impact factor: 4.915

2.  Validating a scoring system for the diagnosis of smear-negative pulmonary tuberculosis in HIV-infected adults.

Authors:  Isabella Coimbra; Magda Maruza; Maria de Fátima Pessoa Militão Albuquerque; Joanna D'Arc Lyra Batista; Maria Cynthia Braga; Líbia Vilela Moura; Demócrito Barros Miranda-Filho; Ulisses Ramos Montarroyos; Heloísa Ramos Lacerda; Laura Cunha Rodrigues; Ricardo Arraes de Alencar Ximenes
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

3.  Accuracy of the QuantiFERON-TB Gold in Tube for diagnosing tuberculosis in a young pediatric population previously vaccinated with Bacille Calmette-Guérin .

Authors:  Marcelo Genofre Vallada; Thelma Suely Okay; Gilda Maria B Del Negro; Claudio Amaral Antonio; Lidia Yamamoto; Sonia Regina T S Ramos
Journal:  Rev Paul Pediatr       Date:  2014-03

4.  Scoring system for the diagnosis of tuberculosis in indigenous children and adolescents under 15 years of age in the state of Mato Grosso do Sul, Brazil.

Authors:  Sandra Christo dos Santos; Ana Maria Campos Marques; Roselene Lopes de Oliveira; Rivaldo Venâncio da Cunha
Journal:  J Bras Pneumol       Date:  2013 Jan-Feb       Impact factor: 2.624

5.  Diagnosis of pulmonary tuberculosis in children and adolescents: comparison of two versions of the Brazilian Ministry of Health scoring system.

Authors:  Roberta Feijó Carvalho; Anna Cristina Calçada Carvalho; Luis Guillermo Coca Velarde; Andrea Maciel de Oliveira Rossoni; Rafaela Baroni Aurilio; Selma Maria de Azevedo Sias; Christiane Mello Schmidt; Adriana da Silva Rezende Moreira; Pedro da Silva Martins; Lorrayne Isidoro Gonçalves; Terezinha Miceli Martire; Ana Paula Ferreira Barbosa; Ana Paula Quintanilha Dos Santos; Roberta Maia de Castro Romanelli; Maria das Graças Rodrigues de Oliveira; Lilian Martins Oliveira Diniz; Andrea Lucchesi de Carvalho; Sheila Cunha Lucena; Maria Letícia Santos Cruz; Mariza Curto Saavedra; Tony Tannous Tahan; Cristina de Oliveira Rodrigues; Afrânio Lineu Kritski; Clemax Couto Sant'Anna; Claudete Aparecida Araújo Cardoso; Maria de Fátima Bazhuni Pombo Sant'Anna
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-10-30       Impact factor: 1.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.